

Your fight against lung
cancer may start or
continue here
OPDIVO, alone or with YERVOY, is an FDA-approved immunotherapy option or combination to treat many types of non-small cell lung cancer (NSCLC)
Your fight against lung
cancer may start or
continue here
OPDIVO, alone or with YERVOY, is an FDA-approved immunotherapy option or combination to treat many types of non-small cell lung cancer (NSCLC)
Actor portrayals.
OPDIVO + YERVOY is a treatment option for certain adults with previously untreated advanced NSCLC that tests positive for PD‐L1
OPDIVO + YERVOY, with chemotherapy, is a treatment option for adults with previously untreated advanced NSCLC
OPDIVO with chemotherapy before surgery, followed by OPDIVO alone after surgery, is a treatment option for adults with early-stage NSCLC
OPDIVO with chemotherapy is a treatment option for adults with early-stage NSCLC before surgery
OPDIVO is a treatment option for adults who have had prior treatments for NSCLC
You and your healthcare provider may have a choice between under-the-skin injections (subcutaneous injection) with OPDIVO Qvantig and intravenous (lV) infusions with OPDIVO
OPDIVO Qvantig cannot be used in combination with YERVOY. OPDIVO, OPDIVO-based combination treatments, OPDIVO Qvantig, and OPDIVO Qvantig-based combination treatments will not work for everyone. Individual results may vary.
We have answers about getting treatment, monitoring, and more